Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 12.74
- Piotroski Score 3.00
- Grade Buy
- Symbol (OLMA)
- Company Olema Pharmaceuticals, Inc.
- Price $12.20
- Changes Percentage (-1.53%)
- Change -$0.19
- Day Low $11.86
- Day High $12.49
- Year High $17.79
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/04/2024
- Fiscal Year End N/A
- Average Stock Price Target $27.00
- High Stock Price Target $30.00
- Low Stock Price Target $24.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.00
- Trailing P/E Ratio -6.56
- Forward P/E Ratio -6.56
- P/E Growth -6.56
- Net Income $-96,655,000
Income Statement
Quarterly
Annual
Latest News of OLMA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Colman Domingo's prison drama 'Sing Sing' is a 'hard' watch. But there's hope, too.
"Sing Sing" is a poignant drama based on a true story about a wrongfully convicted man finding purpose through a prison theater program. Colman Domingo's portrayal of John Whitfield brings to light th...
By USA Today | 2 days ago -
Waymo expands robotaxi service beyond San Francisco to Daly City, Colma
Waymo has expanded its autonomous robotaxi service to the Peninsula, including Daly City, Broadmoor, and Colma. The company aims to enhance rider experience and offer more destinations. Despite critic...
By CBS News | 1 week ago -
Starmer may be the son of a toolmaker, but he speaks for a very different class - and that's a problem for Labour | Dan Evans
Keir Starmer's team aims to reconnect Labour with the working class by highlighting his less-privileged background. However, there is a complex relationship between the new professional-managerial cla...
By The Guardian | 1 month ago
